Company / Net Income
Ginkgo Bioworks Holdings, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$312.8M
FY2025
5-year range
-$2.1B / -$312.8M
FY2021-FY2025
Trend
+42.8%
vs FY2024
Sector context
#179 of 214
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s net income of -$313M is lower than 84% of companies in the Health Care sector (FY2025). Net Income has increased for 3 consecutive years, from -$2.1B in FY2022 to -$313M in FY2025.
Based on SEC 10-K filings.
-$313M in FY2025.
Improved from -$893M to -$313M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 214This company -$312.8M Sector average $442.7M
▼
-170.6% below sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 42.8% year-over-year.
- Ranks #179 out of 214 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$312.8M | +42.8% |
| FY2024 | -$547.0M | +38.7% |
| FY2023 | -$892.9M | +57.6% |
| FY2022 | -$2.1B | -15.0% |
| FY2021 | -$1.8B | -1345.4% |
| FY2020 | -$126.6M | -6.1% |
| FY2019 | -$119.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026